Contaminated polio vaccines: Will the next shot be fired in the courtroom?

Journal of Legal Medicine

Volumn 20, Issue 2, 1999, Pages 223-249

  Goldman, Michael R ^a   Brock, Marisa J ^a  

^a Rudnick and Wolfe   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE;

DRUG CONTAMINATION; DRUG INDUSTRY; HUMAN; LAW SUIT; LEGAL ASPECT; REVIEW; UNITED STATES; VACCINATION;

EID: 0033024083     PISSN: 01947648     EISSN: 1521057X     Source Type: Journal    
DOI: 10.1080/01947649909511088     Document Type: Article

References (45)

1. The Associated Press. 1997. New Flu Strain:Next Epidemic?. Newsday, Dec. 16:A8
2. Shah and Nathanson. 1976. Human Exposure to SV40:Review and Comment. Am. J. Epidemiol, 103:15
3. Carbone, Pass, Rizzo, Marinetti, DiMuzio, Mew, Levine and Procopio. 1994. Simian Virus 40-like DNA Sequences in Human Pleural Mesothelioma. Oncogene, 9:1781
4. Bergsagel, Finegold, Butel, Kupsky and Garcea. 1992. DNA Sequences Similar to Those of Simian Virus 40 in Ependymomas and Choroid Plexus Tumors of Childhood. New Eng. J. Med., 36:988993
5. Spence. 1987. Alternatives to Manufacturer Liability for Injuries Caused by the Sabin-type Oral Polio Vaccine. 28 Wm. & Mary L. Rev.,:711712
6. Wechsler. 1996. A Shot in the Dark. N.Y. Mag., Nov. 11:43
7. Papp. 1997. Monkey Virus in Polio Vaccine Not a Worry, Experts Say. The Ottawa Citizen, Jan. 31:A2
8. 1997. The Fifth Estate:Polio Vaccine. (Canadian Broadcasting Corp. television broadcast, Oct. 21
9. Lewis. Experience with SV40 and Adenovirus-SV40 Hybrids, Biohazards in Biological Research 96 Edited by:Hellman, A., Oxman, M.N., and Pollack, R., 1973
10. Morris, Johnson and Aulisio. 1961. Clinical and Serologic Responses in Volunteers Given Vacuolating Virus (Sv40) by Respiratory Route. Proc. Soc. Exp. Biol. Med., 108:56
11. Shein and Enders. 1962. Multiplication and Cytopathogenicity of Simian Vacuolating Virus 40 Cultures of Human Tissues. Proc. Soc. Exp. Biol. Med., 109:495
12. Koprowski, Ponten and Jensen. 1962. Transformation of Cultures of Human Tissue Infected with SV40. J. Cell Comp. Physiol., 59:281
13. Zhdanov. 1960. Large-scale Practical Trials and Use of Live Poliovirus Vaccine in the USSR. Live Poliovirus Vaccines Second International Conference. 1960, Washington, D.C. pp.576Pan American Health Organization.
14. Carbone, Rizzo and Pass. 1995. Association of Simian Virus 40 with Rodent and Human Mesotheliomas, Dna Tumor Viruses:Oncogenic Mechanisms 75, 79 Edited by:Barbanti-Brodano, G., Bendinelli, M., and Friedman, H.
15. Geissler. 1990. SV40 and Human Brain Tumors. Prog. Med. Virol., 37:211
16. Strickler, H., Simian Virus 40 (SV40):A Possible Human Polyomavirus. Address at DHHS Workshop. pp.323 supra note 15
17. Innis. 1968. Oncogenesis and Poliomyelitis Vaccine. Nature, 219:972
18. Heinonen, Shapiro, Monson, Hartz, Rosenberg and Slone. 1973. Immunization During Pregnancy Against Poliomyelitis and Influenza in Relation to Childhood Malignancy. Int'l J. Epid., 2:229
19. Zoon, K., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.5–6. supra note 15
20. Garcea, R., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.36 supra note 15
21. Lednicky, Garcea, Bergsagel and Butel. 1995. Natural Simian Virus 40 Strains Are Present in Human Choroid Plexus and Ependymoma Tumors. Virology, 212:710
22. Carbone, M., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.61–62. supra note 15
23. Carbone, Cicala, Pompetti, Festa and Levine. 1992. SV40 Induces Mesotheliomas in Hamsters. Proc. Am. A. Cancer Res., 33 Mar.:393
24. Cicala, Pompetti and Carbone. 1993. SV40 Induces Mesothelioma in Hamsters. Am. J. Path., 142 May:1524
25. Matker, Rizzo, Pass, Di Resta, Powers, Mutti, Kast and Carbone. 1998. The Biological Activities of Simian Virus 40 Large-T Antigen and Its Possible Oncogenic Effects in Humans. Monaldi Arch. Chest Dis., 53:193
26. Brown. 1996. Polio Vaccine Linked to Cancer. New Scientist, 2044 Aug. 24:16
27. Mutti, Carbone, Giordano and Giordano. 1998. Simian Virus 40 and Human Cancer. Monaldi Arch. Chest Dis., 53:198
28. Gibbs, A., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.72 supra note 15
29. Pepper, Jasani, Navabi, Winford-Thomas and Gibbs. 1996. Simian Virus 40 Large T Antigen (SV40LTAg) Primer Specific DNA Amplification in Human Pleural Mesothelioma Tissue. Thorax, 51 Nov.:1074
30. Mutti, L., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.77 supra note 15
31. Tongon, M., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.94 supra, note 15
32. Galateau-Salle, F., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.186 supra note 15
33. Galateau-Salle, Bidet, Iwatsubo, Gennetay, Renier, Letourneux, Pairon, Moritz, Brochard, Jaurand and Freymuth. 1998. SV40-like DNA Sequences in Pleural Mesothelioma, Bronchopulmonary Carcinoma, and Non-Malignant Pulmonary Diseases. J. Pathol., 184:252
34. Pacini, Vivaldi, Santoro, Fedele, Fusco, Romei, Basolo and Pinchera. 1998. Simian Virus 40-like DNA Sequences in Human Papillary Thyroid Carcinomas. Oncogene, 16:665
35. Shah, K., Simian Virus 40 (SV40):A Possible Human Polyomavirus. D.H.H.S. Workshop. pp.97 supra note 15
36. Strickler, Rosenberg, Devesa, Hertel, Fraumeni and Goedert. 1998. Contamination of Poliovirus Vaccines with Simian Virus 40 (1955–1963) and Subsequent Cancer Rates. J.A.M.A., 279:292
37. Roggli, Sanfilippo and Shelburne. 1992. Mesothelioma, Pathology of Asbestos and Associated Diseases 383 Edited by:Roggli, V.L., Greenberg, S.D., and Pratt, P.C.
38. Butel and Lednicky. 1999. Cell and Molecular Biology of Simian Virus 40:Implications for Human Infections and Disease. J. Nat'l Cancer Inst., 91:119
39. Carbone, Rizzo and Pass. 1997. Simian Virus 40, Poliovaccines and Human Tumors:A Review of Recent Developments. Oncogene, 15:1877
40. Marini, Iaccheri, Lazzarin, Carcini, Corallini, Gerosa, Iuzzolino, Barbanti-Brodano and Tognon. 1996. SV40 Early Region and Large T-Antigen in Human Brain Tumors, Peripheral Blood Cells and Sperm Fluids from Healthy Individuals. Cancer Res., 56:4820
41. Huff, Levine and Mikalonis. 1994. Medical Monitoring:Who Pays for Medical Surveillance When People Are Exposed to Toxic Substances?. Mich. B.J., 73:1044
42. 1994. “Fear of Cancer”;:Pennsylvania's Temporary Respite from Inadequate Compensation for Victims of Asbestos Exposure. Temp. Envtl. L. & Tech. J., 13:319324
43. Mason. 1998. Don “t Judge All Class Actions by Some Failures. Nat'l L. J., Jan. 19:A23
44. Partner, Rudnick & Wolfe, Chicago, Illinois. Address correspondence to Mr. Goldman at Rudnick & Wolfe, 203 N. LaSalle, Chicago, Illinois 60601.
45. Associate, Rudnick & Wolfe, Chicago, Illinois.